Related Experiment Video
Updated: Jul 9, 2025

06:40
Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
Published on: May 22, 2018
10.7K
A Photoactivatable Norepinephrine for Probing Adrenergic Neural Circuits
Biorxiv : the Preprint Server for Biology
|November 28, 2023
Summary
Researchers developed a novel photo-activatable norepinephrine (NE) called RuBi-NE. This new tool allows for precise, light-activated NE release, enabling detailed studies of noradrenergic circuits in the central nervous system.
Area of Science:
- Neuroscience
- Neurochemistry
- Optogenetics
Background:
- Norepinephrine (NE) is a key neuromodulator influencing attention, arousal, and memory.
- The locus coeruleus (LC) is the primary source of NE in the central nervous system (CNS).
- Existing tools for studying NE lack spatial precision, limiting detailed functional analysis.
Conclusions:
- RuBi-NE is a novel tool for photo-controlled NE release in the visible spectrum.
- This technology allows for high spatial precision in probing noradrenergic circuits.
- Enables investigation of NE's role in both neuronal and non-neuronal CNS cells.
More Related Videos
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K

